Tailoring therapy in colorectal cancer by PET-CT
D. Vriens, L. de Geus-Oei, W. van der Graaf and W. OyenArticles
QJNUCMEDMOLIMA
2009
224--244
Evaluation of different normalization procedures for the calculation of the standardized uptake value in therapy response monitoring studies
D. Vriens, L. de Geus-Oei, H. van Laarhoven, J. Timmer-Bonte, P. Krabbe, E. Visser and W. OyenArticles
NUCMC
2009
550--557
A curve-fitting approach to estimate the arterial plasma input function for the assessment of glucose metabolic rate and response to treatment
D. Vriens, L. de Geus-Oei, W. Oyen and E. VisserArticles
JNM
2009
1933--1939
Chemotherapy response monitoring of colorectal liver metastases by dynamic Gd-DTPA-enhanced MRI perfusion parameters and 18F-FDG PET metabolic rate
D. Vriens, H. van Laarhoven, J. van Asten, P. Krabbe, E. Visser, A. Heerschap, C. Punt, L. de Geus-Oei and W. OyenArticles
JNM
2009
1777--1784
CAR-diology--a virus receptor in the healthy and diseased heart
R. Fischer, W. Poller, H. Schultheiss and M. GotthardtArticles
J Mol Med (Berl)
2009
879--884
A novel method of 18F radiolabeling for PET
W. McBride, R. Sharkey, H. Karacay, C. D'Souza, E. Rossi, P. Laverman, C. Chang, O. Boerman and D. GoldenbergArticles
JNM
2009
991--998
Rosuvastatin increases extracellular adenosine formation in humans in vivo: a new perspective on cardiovascular protection
P. Meijer, W. Oyen, D. Dekker, P. van den Broek, C. Wouters, O. Boerman, G. Scheffer, P. Smits and G. RongenArticles
ATVB
2009
963--968
Dose-response effect of Gelofusine on renal uptake and retention of radiolabelled octreotate in rats with CA20948 tumours
M. Melis, M. Bijster, M. de Visser, M. Konijnenberg, J. de Swart, E. Rolleman, O. Boerman, E. Krenning and M. de JongArticles
EJNMMI
2009
1968--1976
Enhancement of the endothelial NO synthase attenuates experimental diastolic heart failure
D. Westermann, A. Riad, U. Richter, S. Jäger, K. Savvatis, M. Schuchardt, N. Bergmann, M. Tölle, D. Nagorsen, M. Gotthardt, H. Schultheiss and C. TschöpeArticles
Basic Res Cardiol
2009
499--509
Monitoring and predicting response to therapy with 18F-FDG PET in colorectal cancer: a systematic review
L. de Geus-Oei, D. Vriens, H. van Laarhoven, W. van der Graaf and W. OyenArticles
JNM
2009
43S--54S
Altered contractility of skeletal muscle in mice deficient in titin's M-band region
C. Ottenheijm, C. Hidalgo, K. Rost, M. Gotthardt and H. GranzierArticles
JMOLBIOL
2009
10--26
Versatile conjugation of octreotide to dendrimers by cycloaddition ("click") chemistry to yield high-affinity multivalent cyclic Peptide dendrimers
C. Yim, O. Boerman, M. de Visser, M. de Jong, A. Dechesne, D. Rijkers and R. LiskampArticles
Bioconjug Chem
2009
1323--1331
Molecular imaging of solid tumors: exploiting the potential
W. Oyen and W. van der GraafArticles
NATREVCLIONC
2009
609--611
Can antibody galactosylation be used to improve radioimmunotherapy of induced peritoneal carcinomatosis of colonic origin in the rat?
F. Aarts, T. Hendriks, A. Eek, W. Oyen, R. Bleichrodt and O. BoermanArticles
CANBR
2009
29--34
Truncation of titin's elastic PEVK region leads to cardiomyopathy with diastolic dysfunction
H. Granzier, M. Radke, J. Peng, D. Westermann, O. Nelson, K. Rost, N. King, Q. Yu, C. Tschöpe, M. McNabb, D. Larson, S. Labeit and M. GotthardtArticles
CIRCRES
2009
557--564
In vitro growth factor release from injectable calcium phosphate cements containing gelatin microspheres
W. Habraken, O. Boerman, J. Wolke, A. Mikos and J. JansenArticles
JBMRA
2009
614--622
Prospective comparison of [18F]fluorodeoxyglucose positron emission tomography and computed tomography in patients with melanoma with palpable lymph node metastases: diagnostic accuracy and impact on treatment
E. Bastiaannet, T. Wobbes, O. Hoekstra, E. van der Jagt, A. Brouwers, R. Koelemij, J. de Klerk, W. Oyen, S. Meijer and H. HoekstraArticles
JCO
2009
4774--4780
Improved selection of patients for hepatic surgery of colorectal liver metastases with (18)F-FDG PET: a randomized study
T. Ruers, B. Wiering, J. van der Sijp, R. Roumen, K. de Jong, E. Comans, J. Pruim, H. Dekker, P. Krabbe and W. OyenArticles
JNM
2009
1036--1041
Time to target evaluation criteria of targeted therapies
C. van Herpen, W. van der Graaf and W. OyenArticles
NUCMC
2009
487--489